Return Goods Policy

Official Return Goods Policy

APP-22 Alliance Returned Goods Policy · Version 4.0 · Effective September 1, 2026 · A2A Alliance Pharmaceuticals, LLC · 75 Raines Dr, STE B, Franklin, KY 42134

A2A Alliance Pharmaceuticals Return Goods Policy overrides all other Return Goods Policies from distributors, wholesalers, pharmacies, retailers, clinics, and hospitals.

Return Authorization or Destruction Authorization is required to return or dispose of A2A Alliance Pharmaceuticals products. Products will not be credited without an approved Return Authorization or Destruction Authorization, and credit will only be issued if the return or destruction is within the terms of this policy. Return Authorizations and Destruction Authorizations expire sixty (60) days from the date issued.

Return or Destruction Authorization may be obtained by emailing your request to returns@a2aalliancepharma.com.

Returnable Items:

The following products purchased in the US are returnable for return goods credit consideration with prior approval:

A.	Short-dated merchandise, in the original commercial container/packaging and bearing the original product labeling, with six (6) months or less remaining until the expiration date, provided the applicable invoice date is within one (1) year of the return request.
B.	Expired product in the original commercial container/packaging and bearing the original product labeling, according to the applicable manufacturer’s expired-product return policy and any manufacturer-established time limits. For products under Alliance’s labeler code, expired products may be returned within thirty (30) days after the expiration date, provided the applicable invoice date is within one (1) year of the return request.
C.	Product shipped directly that is damaged in transit, subject to FOB terms, or material shipped in error by A2A Alliance Pharmaceuticals.
D.	Discontinued, withdrawn, or recalled merchandise.

Products that receive return authorization from A2A Alliance Pharmaceuticals must be returned to A2A Alliance Pharmaceuticals to be considered for credit.

At the sole discretion of A2A Alliance Pharmaceuticals, eligible products may be authorized for destruction through a reverse distributor, returned goods service contractor, or other qualified third party in lieu of physical return. When destruction is specifically authorized in writing by A2A Alliance Pharmaceuticals, physical return to A2A Alliance Pharmaceuticals will not be required for credit consideration.

Non-Returnable Items (No Credit will be issued):

All products other than those listed above shall be deemed non-returnable. Non-returnable products include, without limitation:

A.	Products with six (6) months or less remaining until the package/container expiration date at the time of shipment by A2A Alliance Pharmaceuticals and accepted by the customer as short-dated merchandise, or products with six (6) months or less remaining until the package/container expiration date for which the applicable invoice date is more than one (1) year before the return request.
B.	Expired products returned outside the applicable manufacturer’s expired-product return period or, for products under Alliance’s labeler code, more than thirty (30) days after expiration or more than one (1) year from the applicable invoice date.
C.	Packages/containers with labels added to or removed from the original manufactured package/containers.
D.	Repackaged product.
E.	If the customer has filed for bankruptcy, or if the products were sold in clearance or similar special sale events.
F.	Product sold on “non-returnable” terms.
G.	Merchandise purchased or otherwise obtained in violation of any federal, state, or local law or regulation.
H.	Merchandise destroyed or damaged from causes such as fire, water, tornado, or other catastrophe, and merchandise that has otherwise deteriorated due to conditions occurring after shipment and beyond the control of A2A Alliance Pharmaceuticals, such as improper storage or handling, heat, cold, smoke, and so forth.
I.	Partial products will not be accepted for credit, except as required by applicable state regulations. For this policy, a “partial product” includes any package or container with a broken safety seal, whether internal or external.
J.	Products destroyed, discarded, donated, transferred, or otherwise disposed of by the customer or any third party without prior written authorization from A2A Alliance Pharmaceuticals.
K.	Products returned with illegible or missing lot numbers and/or expiration dates.
L.	Any finished products that have been opened for use.

Recalls:

M.	Must be returned separately from expired products.
N.	Reference the instructions from the recall notification and/or the FDA-Manufacturer’s instructions for all recalled products. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Damaged in Shipping and Shortages:

A.	Products received damaged may be returned for full credit when reported in writing to A2A Alliance Pharmaceuticals within 72 hours of receipt. Please have the Transportation Company note “damaged” on the freight bill.
B.	A2A Alliance Pharmaceuticals must authorize damaged product returns and issue a Returned Goods Authorization.
C.	Upon request, the buyer shall furnish documentation as required for A2A Alliance Pharmaceuticals to recover loss from the carrier.
D.	Upon receipt of the product, customers are requested to verify the quantities of units received against the original shipping documents by performing a physical count. Any discrepancies must be reported to A2A Alliance Pharmaceuticals within ten (10) days of receipt, at which time the A2A Alliance Pharmaceuticals Regulatory/Quality Assurance Department may initiate an investigation.

Procedure for Returning Items:

All returnable products must be returned to A2A Alliance Pharmaceuticals at the following address:

A2A Alliance Pharmaceuticals
Attn: Returns
75 Raines Dr, STE B
Franklin, KY 42134

Returns of A2A Alliance Pharmaceuticals products must include a packing list containing the following information:

A.	Name, address, and contact information of the facility returning the product
B.	Customer name, address, and contact information
C.	Wholesaler name and address
D.	Reference number
E.	Reason for return
F.	Product information – product description, package size, lot number, expiration date, quantity, PO number, and serial number(s) if applicable
G.	Returns Authorization number

All returns must comply with applicable federal and state laws. A2A Alliance Pharmaceuticals will issue credit for authorized returnable products in accordance with the terms of this policy. All charges associated with the return or destruction of product, including transportation, handling, administrative, processing, reverse distribution, and third-party destruction fees, are the customer’s responsibility and will not be reimbursed unless expressly approved in writing by A2A Alliance Pharmaceuticals. Products returned outside these guidelines will not be accepted, and no credit will be issued.

When destruction has been authorized in writing by A2A Alliance Pharmaceuticals in lieu of physical return, the customer or approved third-party contractor must provide documentation of destruction acceptable to A2A Alliance Pharmaceuticals. Such documentation must identify the product, lot number, expiration date, quantity, and date of destruction, as applicable.

Terms:

A.	Reimbursements will be issued based on the Wholesale acquisition cost (WAC) at the time of return or destruction authorization.
B.	Credits expire one hundred eighty (180) days from the date issued.
C.	Reimbursement will be made in the form of a credit memo applied to the customer’s current account balance or future purchases. Credits will be issued to direct accounts only. Indirect customers, such as retail and hospital pharmacies, will receive credit through their servicing wholesaler.
D.	A2A Alliance Pharmaceuticals will not issue credit or accept charges/deductions for administrative, handling, or freight charges associated with the return of product to A2A Alliance Pharmaceuticals.
E.	A2A Alliance Pharmaceuticals will not be responsible for transportation, handling, processing, or other fees imposed by a customer, wholesaler, distributor, reverse distributor, or third party in connection with the destruction of products unless expressly approved in writing by A2A Alliance Pharmaceuticals.
F.	Credit or reimbursement will not be issued for products destroyed by customers or third parties without prior written authorization from A2A Alliance Pharmaceuticals.
G.	Credit will not be extended when the intent is to temporarily reduce inventory.

Returned Goods Policy is subject to change.

Controlled document: APP-22 Alliance Returned Goods Policy, Version 4.0, effective September 1, 2026 (Change Control CC-520). The signed controlled copy is maintained by A2A Alliance Pharmaceuticals Regulatory/Quality Assurance.